We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

138 hedge funds and large institutions have $1.42B invested in Travere Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $945M → $1.42B (+$478M)

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

17% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 41

3% more funds holding

Funds holding: 134 → 138 (+4)

0.22% more ownership

Funds ownership: 102.24% → 102.46% (+0.22%)

22% less call options, than puts

Call options by funds: $3.51M | Put options by funds: $4.49M

Holders
138
Holders Change
+4
Holders Change %
+2.99%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
48
Reduced
41
Closed
22
Calls
$3.51M
Puts
$4.49M
Net Calls
-$978K
Net Calls Change
-$2.1M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$30.7M
2
Bank of America
Bank of America
North Carolina
+$23M
3
ACA
Avoro Capital Advisors
New York
+$11.1M
4
GTC
Ghost Tree Capital
New York
+$11.1M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$9.96M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$35.5M
2
SCM
Scopia Capital Management
New York
-$13.8M
3
Invesco
Invesco
Georgia
-$11.1M
4
Macquarie Group
Macquarie Group
Australia
-$10.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
76
Erste Asset Management
Austria
$963K – – –
LP
77
LMR Partners
United Kingdom
$899K +$770K +33,000 New
CM
78
CM Management
Florida
$872K +$747K +32,000 New
Invesco
79
Invesco
Georgia
$822K -$11.1M -475,762 -94%
AQR Capital Management
80
AQR Capital Management
Connecticut
$814K +$71.4K +3,058 +11%
PP
81
PDT Partners
New York
$778K -$548K -23,472 -45%
DCM
82
Dupont Capital Management
Delaware
$736K -$47K -2,015 -7%
QSS
83
Quantitative Systematic Strategies
Florida
$731K +$626K +26,818 New
OSAM
84
O'Shaughnessy Asset Management
Connecticut
$677K +$143K +6,121 +33%
Norges Bank
85
Norges Bank
Norway
$673K – – –
AC
86
Athanor Capital
New York
$636K +$162K +6,948 +42%
Principal Financial Group
87
Principal Financial Group
Iowa
$625K +$535K +22,903 New
Fisher Asset Management
88
Fisher Asset Management
Washington
$602K -$99.2K -4,247 -16%
VOYA Investment Management
89
VOYA Investment Management
Georgia
$600K +$155K +6,620 +43%
MAM
90
Martingale Asset Management
Massachusetts
$547K -$1.77M -75,800 -79%
IBT
91
International Biotechnology Trust
United Kingdom
$545K +$467K +20,000 New
Jane Street
92
Jane Street
New York
$523K +$35.8K +1,532 +9%
Susquehanna International Group
93
Susquehanna International Group
Pennsylvania
$514K +$440K +18,864 New
ProShare Advisors
94
ProShare Advisors
Maryland
$510K +$105K +4,516 +32%
SG Americas Securities
95
SG Americas Securities
New York
$499K +$28.6K +1,227 +7%
Squarepoint
96
Squarepoint
New York
$464K +$128K +5,496 +48%
AG
97
Aperio Group
California
$436K +$15.2K +650 +4%
DekaBank Deutsche Girozentrale
98
DekaBank Deutsche Girozentrale
Germany
$386K -$16.3K -700 -5%
SEI Investments
99
SEI Investments
Pennsylvania
$378K -$852K -36,513 -72%
HSBC Holdings
100
HSBC Holdings
United Kingdom
$347K +$298K +12,778 New
2 3
4
5 6

TVTX Hedge Fund Activity: Q4 2020 in Review

138 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2020, worth a combined $1.42B — up 51% from $945M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new TVTX positions and 22 closed out — a net gain of 6 holders — while 48 added to existing stakes and 41 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $30.7M. The largest seller was State Street, exiting entirely with an estimated $35.5M sold.

  • 138 institutional investors held Travere Therapeutics (TVTX) as of Q4 2020, up from 134 in Q3 2020.
  • Funds reported $1.42B of Travere Therapeutics stock for Q4 2020, up 51% quarter-over-quarter.
  • 28 funds opened new Travere Therapeutics positions in Q4 2020 and 22 closed out, a net change of +6 holders.
  • The largest Travere Therapeutics buyer in Q4 2020 was Adage Capital Partners, an estimated $30.7M added.
  • The largest Travere Therapeutics seller in Q4 2020 was State Street, an estimated $35.5M sold.

Based on aggregated 13F filings for Q4 2020.